Information  X 
Enter a valid email address

Aquis Exchange PLC (AQX)

  Print      Mail a friend

Friday 22 November, 2019

Aquis Exchange PLC

Director/PDMR Notification

RNS Number : 4170U
Aquis Exchange PLC
22 November 2019
 

22 November 2019

 

Aquis Exchange PLC ("Aquis Exchange")
Director/PDMR Notification

Aquis Exchange PLC makes the following announcement regarding its Directors' participation in the Aquis Share Incentive Plan.

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alasdair Haynes

2.

Reason for the notification

b)

Position / status

CEO

c)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 


 

GB00BD5JNK30

b)

Nature of the transaction

Alasdair Haynes participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

490p

1,835

 

d)

Aggregated information

-     Aggregated volume

 

 -      Price

 

 

   1,835

 

 

    490p

 

e)

Date of the transaction

21 November 2019

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

 

a)

Position / status

CFO & COO

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 


 

GB00BD5JNK30

b)

Nature of the transaction

Jonathan Clelland participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

490p

1,835

 

d)

Aggregated information

-     Aggregated volume

 

-        Price

 

 

   1,835

 

 

    490p

 

e)

Date of the transaction

21 November 2019

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

Enquiries:
 

Aquis Exchange PLC

Tel: +44 (0) 20 3597 6321

Alasdair Haynes, CEO

 

Jonathan Clelland, CFO and COO

Belinda Keheyan, Head of Marketing

Tel: +44 (0)20 3597 6329

 

 

Liberum Capital Limited (Nominated Adviser and Broker)

Tel: +44 (0) 20 3100 2000

Clayton Bush

 

Chris Clarke

 

Edward Thomas

 

Kane Collings

 

 

 

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Rebecca Sanders-Hewett

[email protected]

Caroline Forde

 

Susie Hudson

 

 

 

Website

http://www.aquis.eu

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFVSLTLFFIA

a d v e r t i s e m e n t